GlassScriptPhysician profile
Marvin Balaan
NPI 1306807615
$1,876.25
in general payments reported to CMS, 2019-2025
17 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $39.21 · 2021: $113 · 2022: $404 · 2023: $413 · 2024: $434 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Education: $22.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.49 |
| Education | $22.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $544.87 | 2019-2024 | Fasenra, Breztri, Airsupra |
| Pulmonx Corporation | $361.63 | 2022-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $292.35 | 2019-2025 | Nucala |
| Verona Pharma, INC. | $131.74 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.56 | 2022-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $115.10 | 2023-2025 | Dupixent |
| Pinnacle Biologics, INC | $100.58 | 2022 | |
| Vapotherm INC | $60.07 | 2019 | |
| Mylan Specialty L.P. | $31.93 | 2021-2022 | |
| Genzyme Corporation | $21.48 | 2025 | |
| Electromed, INC. | $16.79 | 2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $15.48 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.47 | 2021 | |
| Boston Scientific Corporation | $14.06 | 2021 | |
| Amgen INC. | $13.34 | 2024 | Evenity, Prolia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $13.10 | 2019 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Balaan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.